Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Groundbreaking Hydrogel Implant to Help Prevent Endometriosis

By HospiMedica International staff writers
Posted on 18 Jul 2024

Approximately 10% of women are affected by endometriosis, a condition whose origins remain largely unknown. More...

One prevailing theory suggests that endometriosis develops when menstrual blood, carrying cells from the uterine lining, flows backward through the fallopian tubes into the abdominal cavity, where it may cause inflammation, pain, and scar tissue. To address this, researchers have developed a hydrogel implant that effectively blocks the fallopian tubes to stop the backflow of menstrual blood, potentially reducing the risk of developing endometriosis. This implant is designed to be biocompatible, easy to apply, and removable either through exposure to UV light or a special solution, based on tests indicating it does not provoke a foreign body response.

Hydrogels, which are versatile polymers capable of retaining water, have applications ranging from contact lenses to soil hydration. A collaborative effort by teams from ETH Zurich (Zurich, Switzerland) and Empa (Zurich, Switzerland) has led to the creation of this novel hydrogel implant, as reported in a recent publication in the journal Advanced Materials. This dual-purpose implant serves as both a contraceptive and a preventative measure against endometriosis. Introduced non-surgically via a hysteroscope, the hydrogel swells upon contact with bodily fluids, effectively blocking both sperm and menstrual blood from passing through the fallopian tubes.

The researchers meticulously tested the implant's stability and degradability, striving to strike a balance that ensures long-term compatibility and effectiveness. Initial testing was performed ex-vivo on human and animal fallopian tubes removed during medical procedures like ovarian cancer surgery, followed by in-vivo testing in a live pig where the implant remained stable and non-reactive after three weeks. While a patent has been filed for this technology, further development and testing are necessary to prepare it for commercial use. The researchers are actively seeking partnerships within industry and academia to advance this innovation, particularly considering the unique challenges posed by human application and activities such as sports. Additionally, it remains to be seen if blocking the fallopian tubes alone will be enough to fully prevent endometriosis.

“So far, very little research has been done at the point where materials science, process engineering and gynecology meet. But this is a vitally important area of research. We hope that our work will count as a meaningful step in the right direction,” said Inge Herrmann , a member of the research group at the Department of Mechanical and Process Engineering at ETH and Empa.

Related Links:
ETH Zurich
Empa


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Medical-Grade Display
HL2316SHTB
Surgical System
Stealth AXiS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The study is the first to demonstrate a single nanomaterial platform that combines rapid blood clotting, activation of the body’s own latent growth factors, recruitment of bone-forming stem cells and enhanced bone regeneration. (Image Credit: Stef Zingsheim/University of Sydney)

Nanobone Material Activates Natural Repair Signals to Regrow Bone

Cleft lip and palate is a birth defect that affects about 1 in 700 children and occurs when parts of the upper lip or roof of the mouth do not fully fuse during pregnancy. Repairing the resulting jawbone... Read more

Medical Imaging

view channel
Images from patient T1, who had menstrual cycle–dependent right shoulder pain. (A) Maximum-intensity-projection images show abnormal findings for right diaphragm (arrowhead), bilateral round ligaments, peritoneum around bilateral ovaries, and left fallopian tube. Combined PET/MRI show hyperintense lesion with focal uptake inferior of right diaphragm, indicative of endometriosis (arrowhead, B). Confirmatory laparoscopy demonstrated extensive pelvic disease and implants of right diaphragm (C) that stained intensely positive for FAP (D).  (Image Credit: Schindler P, Brandt J, Bobe S, et al. Initial results of FAPI PET/MRI to assess the extent of endometriosis. J Nucl Med. 2026;67(8):1232–1238. doi:10.2967/jnumed.125.271376)

Targeted PET/MRI Improves Detection and Preoperative Mapping of Endometriosis

Endometriosis is a chronic inflammatory condition in which endometrial-like tissue grows outside the uterus, causing pelvic pain, infertility, and reduced quality of life. Conventional imaging can underestimate... Read more

Business

view channel
Image: Sempresto’s Smartphone-Integrated Epinephrine Auto-Injector Wins Red Dot Design Award (Photo courtesy of Sempresto)

Smartphone-Integrated Epinephrine Auto-Injector Concept Wins Red Dot Design Award

Severe allergic reactions can escalate rapidly and require prompt epinephrine, yet many at-risk patients do not consistently carry their auto-injector. With food allergies affecting an estimated 220 million... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.